Verition Fund Management
BVS icon

Verition Fund Management’s Bioventus BVS Stock Holding History

Verition Fund Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-26,224
Closed -$175K – 3544
2025
Q3 		$175K Sell
26,224
-18,245
-41% -$127K ﹤0.01% 3511
2025
Q2 		$294K Buy
44,469
+18,911
+74% +$134K ﹤0.01% 3208
2025
Q1 		$234K Buy
+25,558
New +$255K ﹤0.01% 2990
2024
Q4 		– Sell
-28,512
Closed -$341K – 3261
2024
Q3 		$341K Sell
28,512
-11,007
-28% -$95.2K ﹤0.01% 2557
2024
Q2 		$227K Buy
39,519
+24,100
+156% +$132K ﹤0.01% 2515
2024
Q1 		$80.2K Sell
15,419
-500
-3% -$2.44K ﹤0.01% 2603
2023
Q4 		$83.9K Buy
15,919
+5,133
+48% +$20.3K ﹤0.01% 2156
2023
Q3 		$35.6K Buy
+10,786
New +$37.8K ﹤0.01% 2201
2023
Q2 		– Sell
-30,770
Closed -$32.9K – 2227
2023
Q1 		$32.9K Buy
30,770
+11,814
+62% +$22.6K ﹤0.01% 1983
2022
Q4 		$49.5K Buy
+18,956
New +$82.8K ﹤0.01% 1888

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Verition Fund Management's BVS Position: Q4 2025 in Review

Verition Fund Management sold out of Bioventus (BVS) in Q4 2025, closing a stake of 26,224 shares — an estimated $175K sold.

Verition Fund Management first reported a position in BVS in Q4 2022 and held it in 10 quarters. The position peaked at $341K in Q3 2024. 148 funds tracked by Wall St. Rank hold BVS as of Q4 2025.

  • Verition Fund Management reported no remaining Bioventus position as of Q4 2025 after selling out during the quarter.
  • Verition Fund Management sold 26,224 Bioventus shares in Q4 2025, an estimated $175K.
  • Verition Fund Management first reported a position in Bioventus in Q4 2022 and held it in 10 quarters.
  • Verition Fund Management's Bioventus position peaked at $341K in Q3 2024.
  • 148 funds tracked by Wall St. Rank held Bioventus as of Q4 2025.

Based on Verition Fund Management's 13F filing for Q4 2025, filed 13 Feb 2026.